As of 19 Nov 2026, Aventix has raised $1.4M across 1 verified round on record (amounts in other currencies converted to USD); latest: €1.2M pre-seed round led by Kost Capital and Voima Ventures, announced 30 Sep 2026.
Aventix sells precision measurement instrumentation for laboratories, specifically focusing on a product called Scarlett 01 that assists in bioanalytics and scientific research.
aventix.ioSwedenHealthtech
5 sources · checked 3 times, last 48d ago
GU Ventures invested prior to the round; Vinnova and Västra Götalandsregionen provided separate capital support, not round investment.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed | $1.4M €1.2M | 2026-09-30 | Kost Capital, Voima Ventures | No recent discussion |
5 sources · checked 3 times, last 48d ago [ VERIFIED ] read against 4 of 5 sources GU Ventures invested prior to the round; Vinnova and Västra Götalandsregionen provided separate capital support, not round investment. | ||||
Aventix builds sensor-based laboratory instruments and AI software that help pharmaceutical, chemical, agricultural, cosmetic, and other research labs measure liquid volumes accurately and create trustworthy data.
Aventix says laboratories generate more experimental data than they can trust because inconsistent and unverified measurements undermine reproducibility and leave AI models without reliable training data. Its €1.2 million pre-seed financing, led by Kost Capital and Voima Ventures, is funding the commercial rollout of Scarlett 01 through an Early Access Program in North America and Europe after independent validation by VTT MIKES.
Checked against 8 sources on Oct 1
Also named as backers in company research: GU Ventures, Vinnova, Västra Götalandsregionen, NVIDIA Inception Program